CD47 and atherosclerosis: CD47 antibody B6H12 downregulates VEGFR2 and SHP-2 phosphorylation [46] and CD47 binds SIRPα and TSP-1 to regulate the expression of VEGF and VEGFR2, thereby affecting the progression of atherosclerosis.